연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
767. Preliminary results of pre-radiation neck dissection in head and neck cancer patients undergoing organ preservation treatment.
Jeong WJ, Jung EJ, Hah JH, Kwon TK, Wu HG, Heo DS, Sung MW, Kim KH.
Acta Otolaryngol Suppl. 2007 Oct;(558):121-7
Link
766. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH.
Lung Cancer. 2007 Nov 22
Link
765. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.
Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
BMC Cancer. 2007 Nov 1;7:203.
Link
764. Artificial nutrition and hydration in terminal cancer patients: the real and the ideal.
Oh do Y, Kim JH, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ, Kim NK.
Support Care Cancer. 2007 Jun;15(6):631-6. Epub 2006 Nov 11
Link
763. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW, Jeon YK, Lee KH, Keam B, Hwang PG, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Heo DS, Bang YJ, Kim TY.
Pharmacogenet Genomics. 2007 May;17(5):313-9.
Link
762. A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.
Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Kim SW, Heo DS, Yoon YB, Bang YJ.
Ann Oncol. 2008 Jan;19(1):99-103. Epub 2007 Sep 9
Link
761. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
BMC Cancer. 2007 Apr 12;7:63.
Link
760. Palliative chemotherapy for pulmonary pleomorphic carcinoma.
Bae HM, Min HS, Lee SH, Kim DW, Chung DH, Lee JS, Kim YW, Heo DS.
Lung Cancer. 2007 Oct;58(1):112-5. Epub 2007 Jun 18.
Link
759. Nonsurgical treatment of an incompletely excised primary adenocarcinoma of nonpigmented ciliary epithelium.
Lee SW, Park SH, Kim IH, Chung H, Kim TY, Heo DS.
Tumori. 2007 Sep-Oct;93(5):514-7
Link
758. Chemotherapy use and associated factors among cancer patients near the end of life.
Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, Lee CG, Choi YS, Hong YS, Kim SY, Heo DS.
Oncology. 2007;72(3-4):164-71. Epub 2007 Dec 20
Link